Scientific Literature Search

Open access

Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients.

Kumar M, Feldman RA.

Hum Mol Genet · 2025-12-01

DOI: 10.1093/hmg/ddaf166PMID: 41224733

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases.

Portaro G, Giacomelli M, Grisanti S, Taruffi L, Di Rauso G, Fioravanti V, Salomone G, Argenziano G, Sabadini R, Toschi G, Iotti O, Campanini I, Merlo A, Cavazzuti L, Damiano B, Scaltriti S, Scaglioni A, Paul JJ, Bauer P, Biagini G, Monfrini E, Di Fonzo A, Montepietra S, Valzania F, Vecchi M, Cavallieri F, FABIP-PD STUDY-GROUP.

Parkinsonism Relat Disord · 2025-11-26

DOI: 10.1016/j.parkreldis.2025.108134PMID: 41317599

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

Lanore A, Tesson C, Basset A, Lejeune FX, Cogan G, Mangone G, Sambin S, Bertille N, Anheim M, Arnulf I, Ansquer S, Brandel JP, Brefel-Courbon C, Defebvre L, Drapier S, Eusebsio A, Fabbri M, Giordana C, Hainque E, Lehericy S, Marques A, Moreau C, Moro E, Ory F, Rolland AS, Thobois S, Vidailhet M, Devos D, Mariani LL, Lesage S, Brice A, Corvol JC, Predistim study group, Iceberg study group, NSPark study group.

NPJ Parkinsons Dis · 2025-11-21

DOI: 10.1038/s41531-025-01204-8PMID: 41271783

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

A novel peptide-based strategy to enhance GBA1 expression for treating Parkinson's disease.

Kim H, Na J, Ryu HG, Lee E, Park H, Park H, Nam Y, Jeong GH, Pyo IH, Choi JH, Nah J, Jang SM, Song JH, Cho SJ, Kim S.

NPJ Parkinsons Dis · 2025-11-19

DOI: 10.1038/s41531-025-01175-wPMID: 41258150

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Parkinson's-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa.

Mark JR, Staley HA, Titus AM, Agin-Liebes J, Garrido A, Hughes L, Dzamko N, Wallings RL, Tansey MG.

Mov Disord · 2025-11-19

DOI: 10.1002/mds.70123PMID: 41257354

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

GBA1 Gene-Associated Transcriptomic Signatures Reveal Risk Genes in Parkinson's Disease.

Liu Y, Luo X, Fleming RMT.

Biomedicines · 2025-11-17

DOI: 10.3390/biomedicines13112799PMID: 41301891

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility.

Parlar SC, Lee Y, Gan-Or Z.

Mov Disord · 2025-11-15

DOI: 10.1002/mds.70127PMID: 41239902

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant.

Kamo H, Oyama G, Shimizu M, Takeshige-Amano H, Ogawa T, Sako W, Nishikawa N, Hatano T, Li Y, Yoshino H, Funayama M, Ito M, Iwamuro H, Umemura A, Hattori N.

Mov Disord Clin Pract · 2025-11-13

DOI: 10.1002/mdc3.70411PMID: 41230957

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variants.

Slingerland S, de Meyer EKR, van der Horn HJ, Carli G, Slomp AC, d'Angremont E, Boertien JM, Goethals I, Meles SK, van der Zee S, van Laar T.

NPJ Parkinsons Dis · 2025-11-12

DOI: 10.1038/s41531-025-01160-3PMID: 41224771

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant.

Avenali M, Artusi CA, Cilia R, Giannini G, Cuconato G, Albanese A, Golfrè Andreasi N, Antenucci P, Antonini A, Avanzino L, Baldelli L, Bentivoglio AR, Bove F, Bozzali M, Calandra-Buonaura G, Cani I, Carelli V, Cavallieri F, Cocco A, Cogiamanian F, Colucci F, Cortelli P, De Biase A, Di Biasio F, Di Fonzo A, D'Onofrio V, Eleopra R, Elia AE, Fioravanti V, Genovese D, Guerra A, Imarisio A, Ledda C, Liccari M, Longo C, Lopiano L, Malaguti MC, Malito R, Mameli F, Marino S, Minardi R, Mitrotti P, Monfrini E, Pacchetti C, Piano C, Rispoli V, Rizzone MG, Romito LM, Sambati L, Sensi M, Sorbera C, Spagnolo F, Tassorelli C, Valentino F, Valzania F, Zangaglia R, Zibetti M, Italian PARKNET Study Group, Valente EM.

Neurology · 2025-10-22

DOI: 10.1212/wnl.0000000000214036PMID: 41124650

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation.

Bove F, Genovese D, De Biase A, Albanese A, Antonini A, Artusi CA, Avanzino L, Avenali M, Baldelli L, Calandra-Buonaura G, Cani I, Casasoli N, Cavallieri F, Cilia R, Cocco A, Colucci F, Di Biasio F, D'Onofrio V, Eleopra R, Fioravanti V, Giannini G, Golfre' Andreasi N, Guerra A, Imbalzano G, Izzo A, Ledda C, Liccari M, Lopiano L, Malaguti MC, Minardi R, Mitrotti P, Romito LM, Valente EM, Valzania F, Zangaglia R, Calabresi P, Piano C, Bentivoglio AR, Italian PARKNET Study.

NPJ Parkinsons Dis · 2025-10-17

DOI: 10.1038/s41531-025-01140-7PMID: 41107307

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1 L444P/WT mouse model: implications for Parkinson's disease pathogenesis.

Menozzi E, Geiger M, Meslier V, Fierli F, Gilles M, Chau KY, David A, Shahar Golan R, Famechon A, Koletsi S, Morabito C, Quinquis B, Pons N, Ehrlich SD, Macnaughtan J, Almeida M, Schapira AH.

Front Neurosci · 2025-10-01

DOI: 10.3389/fnins.2025.1546203PMID: 41103722

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

404 articles found

Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients.

Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases.

Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis.

A novel peptide-based strategy to enhance GBA1 expression for treating Parkinson's disease.

Parkinson's-Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa.

GBA1 Gene-Associated Transcriptomic Signatures Reveal Risk Genes in Parkinson's Disease.

GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility.

Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant.

Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variants.

Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a <i>GBA1</i> Pathogenic Variant.

Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation.

Exploring the relationship between <i>GBA1</i> host genotype and gut microbiome in the <i>GBA1</i> <sup>L444P/WT</sup> mouse model: implications for Parkinson's disease pathogenesis.

Filters